Welcome to the homepage of LBI-HTA !
The LBI-HTA is an acadmic non-profit institute and belongs to the Ludwig Boltzmann Society. At our website we wish to present our research and give support for health care decision-making. Here all of our reports are available for free. For further information please contact the LBI-HTA team.
Horizon Scanning in Onkology - Reports
We are pleased to introduce our two new HSO reports.
Health care personnel regularly carrying out invasive procedures have a higher risk for exposure with HCV positive blood through needle stick injuries The aim of this study was to analyse the appropriateness of preoperative/preinterventional HCV testing in patients using available data on the prevalence and transmission risk and in comparison to international guideline recommendations.
Recent national and international reports were retrieved for estimates of HCV prevalence and incidence in Austria. Data on hepatitis C as an occupational disease were provided by the AUVA. We defined the factors influencing the patient- provider transmission risk and systematically searched the literature for studies on transmission risk and guidelines with recommendations on HCV screening or transmission prevention.
The effectiveness of HCV-tests in patients to prevent infections in HCW or even reduced needle-stick injuries is not supported by evidence. Current guidelines recommend to universally apply precautions to minimise needle stick injuries. Recommendations on preoperative HCV screening prior to elective surgeries are based on expert consensus: no clinical studies could be identified that analysed the effectiveness of the testing on infection prevention.
Publication: Decision Support Document No. 102: http://eprints.hta.lbg.ac.at/1103/
Contact: Agnes Kisser
Outpatient cardiac rehabilitation part VI: prospective multi-centre cohort study (comparing patients with and without phase III)
In 2012, we published the study protocol of a prospective multi-centre cohort study (http://eprints.hta.lbg.ac.at/971/) that aimed at comparing patients who attended an outpatient phase III cardiac rehabilitation after phase II with patients who did not. We defined the mean between group difference of risk factors out of the target range at the end of the observation period as the primary outcome. Now, we report on the results: 16 months after Phase II Rehabilitation, this (adjusted) mean difference was -0,06 [-0.7; 0.6] (non-significant). Roughly spoken, about one out of twenty IG patients (6 of 100) of the sample showed one risk factor out of the target range less than a KG patient. In secondary endpoints, only the change in the exercise stress test (percental increase) and the frequency of inpatient re-rehabilitation showed a statistically significant group difference in favour of the intervention. The higher than expected drop-out should be considered when interpreting the results.
Publication: LBI-HTA Project report no. 90: http://eprints.hta.lbg.ac.at/1101/
Contact: Brigitte Piso
We are pleased to introduce our new HSO report.
Update Re-orientation of the Austrian parent-child preventive care programme Part IX: Recommendations from evidence-based guidelines for screening measures covering early childhood (0-6 yrs.)
We are pleased to present an update report covering evidence-based, international screening recommendations for children (0-6 years). Based on the extensive, original report part IX from 2013 an update was performed in terms of new or updated screening recommendations for children.
Publication: HTA Project report No. 62 - Update 2016: http://eprints.hta.lbg.ac.at/996/
Contact: Brigitte Piso
We are pleased to introduce our new reports.
Decision Support Documents 2016:
DSD 97: Leadless pacemakers for right ventricle pacin
DSD 98: Single-step scaffold-based cartilage repair in the knee
DSD 99: Radiofrequency denervation for sacroiliac and facet joint pain
DSD 100: Upper airway stimulation for moderate-to-severe sleep apnea
DSD 101: Magnetic sphincter augmentation device (MSAD) in patients with gastroesophageal reflux disease (GERD)
DSD 24/Update 2016:
Percutaneous transluminal coronary angioplasty (PTCA) with drug-eluting balloon (DEB)